Medicare Advantage
AHA on Oct. 19 submitted a statement to the House Energy and Commerce Health Subcommittee on legislative proposals involving Medicare.
The Centers for Medicare & Medicaid Services released its star ratings for 2024 Medicare Advantage and prescription drug plans, which are available through the Find Plans tool at Medicare.gov.
Responding to a request for stakeholder input, AHA shared (LINK) with the House Budget Committee Health Care Task Force its recommendations to make health care more affordable without compromising access to high quality care.
AHA urged the Centers for Medicare & Medicaid Services to rigorously enforce changes that were included in the calendar year 2024 Medicare Advantage final rule to improve how coverage works for enrollees, promote more timely access to care, ensure better alignment and coverage parity between鈥
AHA Urges CMS to Rigorously Enforce New Policies to Safeguard MA Coverage
The Centers for Medicare & Medicaid Services Sept. 26鈥痳eleased premium and cost-sharing information for Medicare Advantage and Part D prescription drug plans for the 2024 calendar year.
The Health and Human Services Office of Inspector General Aug. 28 released a strategic plan to align its audits, evaluations, investigations and enforcement of managed care plans in Medicare Advantage and Medicaid.
In an Aug. 28 letter to House sponsors, the AHA voiced support for the GOLD Card Act of 2023 (H.R. 4968) that would exempt qualifying providers from prior authorization requirements under Medicare Advantage plans.
AHA voices support of the GOLD Card Act of 2023 (H.R. 4968).
The 黑料正能量 Association would like to provide feedback on sections of H.R. 4822, the 鈥淗ealth Care Price Transparency Act of 2023,鈥 as well as H.R. 3284, the 鈥淧roviders and Payers COMPETE Act.鈥